Buscar
Mostrando ítems 1-9 de 9
Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
(Dovepress, 2017)
A new automated real-time PCR assay for the detection of rifampicin (RIF) and
isoniazid (INH) resistance in Mycobacterium tuberculosis (MTB) was evaluated. A total of 163
clinical samples (128 pulmonary and 35 extra-pulmonary) ...
Evaluation of the GenoType Mycobacteria Direct Assay for Detection of Mycobacterium tuberculosis Complex and Four Atypical Mycobacterial Species in Clinical Samples
(American Society for Microbilogy, 2006)
We evaluated GenoType Mycobacteria Direct (GTMD), a novel commercial assay based on nucleic acid sequence-based amplification technology, for the detection of Mycobacterium tuberculosis complex, M. avium, M. intracellulare, ...
Comparison of Two Molecular Methods for Rapid Diagnosis of Extrapulmonary Tuberculosis
(American Society for Microbilogy, 2011)
Application of real-time PCR for the detection of
Mycobacterium tuberculosis
enables results to be obtained
in about 2 h. A total of 340 nonrespiratory samples were processed using two real-time PCR assay kits: ...
Evaluación de dos pruebas de inmunocromatografía para la identificación de micobacterias del Complejo M. Tuberculosis
(Comité Organizador 23SAMPAC, 2010)
Xpert MTB/RIF kit en el diagnóstico de tuberculosis de muestras no respiratorias
(Comité Organizador 23SAMPAC, 2010)
La detección rápida de M. tuberculosis (MTB) es uno de los objetivos de fundamentales
de la OMS y el empleo de técnicas de amplificación de ácidos nucleicos es
cada día mas habitual en los laboratorios avanzados, sin ...
Aislamientos de Mycobacterium tuberculosis resistentes a fármacos de segunda línea
(Comité Organizador 26SAMPAC, 2013)
La incidencia de cepas de Mycobacterium tuberculosis multiresistentes y la aparición de cepas
Extremadamente resistentes, requiere que se hagan estudios de sensibilidad in vitro con fármacos distintos
a los de primera ...